1. Home
  2. Pharma & Healthcare
  3. Global Preimplantation Genetic Diagnostics (PGD) Market Growth (Status and Outlook) 2020-2025

Global Preimplantation Genetic Diagnostics (PGD) Market Growth (Status and Outlook) 2020-2025

Publication Month: May 2020 | No. of Pages: 158 Published By: LP Information
Single User License: US $ 3660
Corporate User License: US $ 7320

COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.

According to this latest study, the 2020 growth of Preimplantation Genetic Diagnostics (PGD) will have significant change from previous year. By the most conservative estimates of global Preimplantation Genetic Diagnostics (PGD) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Preimplantation Genetic Diagnostics (PGD) market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Preimplantation Genetic Diagnostics (PGD) market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Preimplantation Genetic Diagnostics (PGD), covering the supply chain analysis, impact assessment to the Preimplantation Genetic Diagnostics (PGD) market size growth rate in several scenarios, and the measures to be undertaken by Preimplantation Genetic Diagnostics (PGD) companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
Preimplantation Genetic Screening
Preimplantation Genetic Diagnosis

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
Fertility Clinics
Academic Medical Centers
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Illumina, Inc.
Yikon Genomics
Thermo Fisher Scientific Inc.
Perkinelmer, Inc.
Cooper Surgical
Agilent Technologies, Inc.
Rubicon Genomics
ABBott Laboratories
Oxford Gene Technology
Natera, Inc.
Nidacon International
Merck
Vitrolife AB
Scigene
Hamilton Thorne
Genea Limited
IVFtech
FUJIFILM Irvine Scientific
Beijing Genomics Institute (BGI)
INVO Bioscience
Cook Medical
CellCura
Gonagen Medikal

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Preimplantation Genetic Diagnostics (PGD) market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Preimplantation Genetic Diagnostics (PGD) market by identifying its various subsegments.
Focuses on the key global Preimplantation Genetic Diagnostics (PGD) players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Preimplantation Genetic Diagnostics (PGD) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Preimplantation Genetic Diagnostics (PGD) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
1.7 What is the Impact of Covid-19 Outbreak On the Preimplantation Genetic Diagnostics (PGD)?
1.7.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
1.7.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
1.7.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Preimplantation Genetic Diagnostics (PGD) Market Size in 2020, by Scenario
1.7.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Preimplantation Genetic Diagnostics (PGD) Market Size 2015-2025
2.1.2 Preimplantation Genetic Diagnostics (PGD) Market Size CAGR by Region
2.2 Preimplantation Genetic Diagnostics (PGD) Segment by Type
2.2.1 Preimplantation Genetic Screening
2.2.2 Preimplantation Genetic Screening
2.3 Preimplantation Genetic Diagnostics (PGD) Market Size by Type
2.3.1 Global Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Type (2015-2020)
2.3.2 Global Preimplantation Genetic Diagnostics (PGD) Market Size Growth Rate by Type (2015-2020)
2.4 Preimplantation Genetic Diagnostics (PGD) Segment by Application
2.4.1 Fertility Clinics
2.4.2 Academic Medical Centers
2.4.3 Others
2.5 Preimplantation Genetic Diagnostics (PGD) Market Size by Application
2.5.1 Global Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Application (2015-2020)
2.5.2 Global Preimplantation Genetic Diagnostics (PGD) Market Size Growth Rate by Application (2015-2020)

3 Global Preimplantation Genetic Diagnostics (PGD) by Players
3.1 Global Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Players
3.1.1 Global Preimplantation Genetic Diagnostics (PGD) Market Size by Players (2018-2020)
3.1.2 Global Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Players (2018-2020)
3.2 Global Preimplantation Genetic Diagnostics (PGD) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Preimplantation Genetic Diagnostics (PGD) by Regions
4.1 Preimplantation Genetic Diagnostics (PGD) Market Size by Regions
4.2 Americas Preimplantation Genetic Diagnostics (PGD) Market Size Growth
4.3 APAC Preimplantation Genetic Diagnostics (PGD) Market Size Growth
4.4 Europe Preimplantation Genetic Diagnostics (PGD) Market Size Growth
4.5 Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size Growth

5 Americas
5.1 Americas Preimplantation Genetic Diagnostics (PGD) Market Size by Countries
5.2 Americas Preimplantation Genetic Diagnostics (PGD) Market Size by Type
5.3 Americas Preimplantation Genetic Diagnostics (PGD) Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Preimplantation Genetic Diagnostics (PGD) Market Size by Regions
6.2 APAC Preimplantation Genetic Diagnostics (PGD) Market Size by Type
6.3 APAC Preimplantation Genetic Diagnostics (PGD) Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Preimplantation Genetic Diagnostics (PGD) by Countries
7.2 Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Type
7.3 Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Preimplantation Genetic Diagnostics (PGD) by Countries
8.2 Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Type
8.3 Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Preimplantation Genetic Diagnostics (PGD) Market Forecast
10.1 Global Preimplantation Genetic Diagnostics (PGD) Market Size Forecast (2021-2025)
10.2 Global Preimplantation Genetic Diagnostics (PGD) Forecast by Regions
10.2.1 Global Preimplantation Genetic Diagnostics (PGD) Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Preimplantation Genetic Diagnostics (PGD) Forecast by Type
10.8 Global Preimplantation Genetic Diagnostics (PGD) Forecast by Application

11 Key Players Analysis
11.1 Illumina, Inc.
11.1.1 Company Details
11.1.2 Preimplantation Genetic Diagnostics (PGD) Product Offered
11.1.3 Illumina, Inc. Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 Illumina, Inc. News
11.2 Yikon Genomics
11.2.1 Company Details
11.2.2 Preimplantation Genetic Diagnostics (PGD) Product Offered
11.2.3 Yikon Genomics Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 Yikon Genomics News
11.3 Thermo Fisher Scientific Inc.
11.3.1 Company Details
11.3.2 Preimplantation Genetic Diagnostics (PGD) Product Offered
11.3.3 Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 Thermo Fisher Scientific Inc. News
11.4 Perkinelmer, Inc.
11.4.1 Company Details
11.4.2 Preimplantation Genetic Diagnostics (PGD) Product Offered
11.4.3 Perkinelmer, Inc. Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 Perkinelmer, Inc. News
11.5 Cooper Surgical
11.5.1 Company Details
11.5.2 Preimplantation Genetic Diagnostics (PGD) Product Offered
11.5.3 Cooper Surgical Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 Cooper Surgical News
11.6 Agilent Technologies, Inc.
11.6.1 Company Details
11.6.2 Preimplantation Genetic Diagnostics (PGD) Product Offered
11.6.3 Agilent Technologies, Inc. Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 Agilent Technologies, Inc. News
11.7 Rubicon Genomics
11.7.1 Company Details
11.7.2 Preimplantation Genetic Diagnostics (PGD) Product Offered
11.7.3 Rubicon Genomics Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 Rubicon Genomics News
11.8 ABBott Laboratories
11.8.1 Company Details
11.8.2 Preimplantation Genetic Diagnostics (PGD) Product Offered
11.8.3 ABBott Laboratories Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2020)
11.8.4 Main Business Overview
11.8.5 ABBott Laboratories News
11.9 Oxford Gene Technology
11.9.1 Company Details
11.9.2 Preimplantation Genetic Diagnostics (PGD) Product Offered
11.9.3 Oxford Gene Technology Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2020)
11.9.4 Main Business Overview
11.9.5 Oxford Gene Technology News
11.10 Natera, Inc.
11.10.1 Company Details
11.10.2 Preimplantation Genetic Diagnostics (PGD) Product Offered
11.10.3 Natera, Inc. Preimplantation Genetic Diagnostics (PGD) Revenue, Gross Margin and Market Share (2018-2020)
11.10.4 Main Business Overview
11.10.5 Natera, Inc. News
11.11 Nidacon International
11.12 Merck
11.13 Vitrolife AB
11.14 Scigene
11.15 Hamilton Thorne
11.16 Genea Limited
11.17 IVFtech
11.18 FUJIFILM Irvine Scientific
11.19 Beijing Genomics Institute (BGI)
11.20 INVO Bioscience
11.21 Cook Medical
11.22 CellCura
11.23 Gonagen Medikal

12 Research Findings and Conclusion

Tables and Figures

List of Tables
Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Preimplantation Genetic Diagnostics (PGD) Market Size in 2020, by Scenario
Table 2. COVID-19: Measures to be Undertaken by Preimplantation Genetic Diagnostics (PGD) Companies
Table 3. Research Methodology
Table 4. Data Source
Table 5. Preimplantation Genetic Diagnostics (PGD) Market Size CAGR by Region 2015-2025 ($ Millions)
Table 6. Major Players of Preimplantation Genetic Screening
Table 7. Major Players of Preimplantation Genetic Diagnosis
Table 8. Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2014-2019) ($ Millions)
Table 9. Global Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Type (2015-2020)
Table 10. Global Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2015-2020) ($ Millions)
Table 11. Global Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Application (2015-2020)
Table 12. Global Preimplantation Genetic Diagnostics (PGD) Revenue by Players (2018-2020) ($ Millions)
Table 13. Global Preimplantation Genetic Diagnostics (PGD) Revenue Market Share by Players (2018-2020)
Table 14. Global Preimplantation Genetic Diagnostics (PGD) Key Players Head office and Products Offered
Table 15. Preimplantation Genetic Diagnostics (PGD) Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Preimplantation Genetic Diagnostics (PGD) Market Size by Regions 2015-2020 ($ Millions)
Table 19. Global Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Regions 2015-2020
Table 20. Americas Preimplantation Genetic Diagnostics (PGD) Market Size by Countries (2015-2020) ($ Millions)
Table 21. Americas Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Countries (2015-2020)
Table 22. Americas Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2015-2020) ($ Millions)
Table 23. Americas Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Type (2015-2020)
Table 24. Americas Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2015-2020) ($ Millions)
Table 25. Americas Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Application (2015-2020)
Table 26. APAC Preimplantation Genetic Diagnostics (PGD) Market Size by Regions (2015-2020) ($ Millions)
Table 27. APAC Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Regions (2015-2020)
Table 28. APAC Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2015-2020) ($ Millions)
Table 29. APAC Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Type (2015-2020)
Table 30. APAC Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2015-2020) ($ Millions)
Table 31. APAC Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Application (2015-2020)
Table 32. Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Countries (2015-2020) ($ Millions)
Table 33. Europe Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Countries (2015-2020)
Table 34. Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2015-2020) ($ Millions)
Table 35. Europe Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Type (2015-2020)
Table 36. Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2015-2020) ($ Millions)
Table 37. Europe Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Application (2015-2020)
Table 38. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Countries (2015-2020) ($ Millions)
Table 39. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Countries (2015-2020)
Table 40. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2015-2020) ($ Millions)
Table 41. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Type (2015-2020)
Table 42. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2015-2020) ($ Millions)
Table 43. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Application (2015-2020)
Table 44. Key and Potential Regions of Preimplantation Genetic Diagnostics (PGD)
Table 45. Key Application and Potential Industries of Preimplantation Genetic Diagnostics (PGD)
Table 46. Key Challenges of Preimplantation Genetic Diagnostics (PGD)
Table 47. Key Trends of Preimplantation Genetic Diagnostics (PGD)
Table 48. Global Preimplantation Genetic Diagnostics (PGD) Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 49. Global Preimplantation Genetic Diagnostics (PGD) Market Size Market Share Forecast by Regions
Table 50. Global Preimplantation Genetic Diagnostics (PGD) Market Size Forecast by Type (2021-2025) ($ Millions)
Table 51. Global Preimplantation Genetic Diagnostics (PGD) Market Size Market Share Forecast by Type (2021-2025)
Table 52. Global Preimplantation Genetic Diagnostics (PGD) Market Size Forecast by Application (2021-2025) ($ Millions)
Table 53. Global Preimplantation Genetic Diagnostics (PGD) Market Size Market Share Forecast by Application (2021-2025)
Table 54. Illumina, Inc. Details, Company Total Revenue (in $ million), Head Office, Preimplantation Genetic Diagnostics (PGD) Major Market Areas and Its Competitors
Table 55. Illumina, Inc. Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 56. Illumina, Inc. Preimplantation Genetic Diagnostics (PGD) Revenue and Gross Margin (2018-2020E)
Table 57. Illumina, Inc. Main Business
Table 58. Illumina, Inc. Latest Developments
Table 59. Yikon Genomics Details, Company Total Revenue (in $ million), Head Office, Preimplantation Genetic Diagnostics (PGD) Major Market Areas and Its Competitors
Table 60. Yikon Genomics Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 61. Yikon Genomics Main Business
Table 62. Yikon Genomics Preimplantation Genetic Diagnostics (PGD) Revenue and Gross Margin (2018-2020E)
Table 63. Yikon Genomics Latest Developments
Table 64. Thermo Fisher Scientific Inc. Details, Company Total Revenue (in $ million), Head Office, Preimplantation Genetic Diagnostics (PGD) Major Market Areas and Its Competitors
Table 65. Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 66. Thermo Fisher Scientific Inc. Main Business
Table 67. Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnostics (PGD) Revenue and Gross Margin (2018-2020E)
Table 68. Thermo Fisher Scientific Inc. Latest Developments
Table 69. Perkinelmer, Inc. Details, Company Total Revenue (in $ million), Head Office, Preimplantation Genetic Diagnostics (PGD) Major Market Areas and Its Competitors
Table 70. Perkinelmer, Inc. Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 71. Perkinelmer, Inc. Main Business
Table 72. Perkinelmer, Inc. Preimplantation Genetic Diagnostics (PGD) Revenue and Gross Margin (2018-2020E)
Table 73. Perkinelmer, Inc. Latest Developments
Table 74. Cooper Surgical Details, Company Total Revenue (in $ million), Head Office, Preimplantation Genetic Diagnostics (PGD) Major Market Areas and Its Competitors
Table 75. Cooper Surgical Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 76. Cooper Surgical Main Business
Table 77. Cooper Surgical Preimplantation Genetic Diagnostics (PGD) Revenue and Gross Margin (2018-2020E)
Table 78. Cooper Surgical Latest Developments
Table 79. Agilent Technologies, Inc. Details, Company Total Revenue (in $ million), Head Office, Preimplantation Genetic Diagnostics (PGD) Major Market Areas and Its Competitors
Table 80. Agilent Technologies, Inc. Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 81. Agilent Technologies, Inc. Main Business
Table 82. Agilent Technologies, Inc. Preimplantation Genetic Diagnostics (PGD) Revenue and Gross Margin (2018-2020E)
Table 83. Agilent Technologies, Inc. Latest Developments
Table 84. Rubicon Genomics Details, Company Total Revenue (in $ million), Head Office, Preimplantation Genetic Diagnostics (PGD) Major Market Areas and Its Competitors
Table 85. Rubicon Genomics Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 86. Rubicon Genomics Main Business
Table 87. Rubicon Genomics Preimplantation Genetic Diagnostics (PGD) Revenue and Gross Margin (2018-2020E)
Table 88. Rubicon Genomics Latest Developments
Table 89. ABBott Laboratories Details, Company Total Revenue (in $ million), Head Office, Preimplantation Genetic Diagnostics (PGD) Major Market Areas and Its Competitors
Table 90. ABBott Laboratories Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 91. ABBott Laboratories Main Business
Table 92. ABBott Laboratories Preimplantation Genetic Diagnostics (PGD) Revenue and Gross Margin (2018-2020E)
Table 93. ABBott Laboratories Latest Developments
Table 94. Oxford Gene Technology Details, Company Total Revenue (in $ million), Head Office, Preimplantation Genetic Diagnostics (PGD) Major Market Areas and Its Competitors
Table 95. Oxford Gene Technology Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 96. Oxford Gene Technology Main Business
Table 97. Oxford Gene Technology Preimplantation Genetic Diagnostics (PGD) Revenue and Gross Margin (2018-2020E)
Table 98. Oxford Gene Technology Latest Developments
Table 99. Natera, Inc. Details, Company Total Revenue (in $ million), Head Office, Preimplantation Genetic Diagnostics (PGD) Major Market Areas and Its Competitors
Table 100. Natera, Inc. Preimplantation Genetic Diagnostics (PGD) Product Offered
Table 101. Natera, Inc. Main Business
Table 102. Natera, Inc. Preimplantation Genetic Diagnostics (PGD) Revenue and Gross Margin (2018-2020E)
Table 103. Natera, Inc. Latest Developments
Table 104. Nidacon International Details, Company Total Revenue (in $ million), Head Office, Preimplantation Genetic Diagnostics (PGD) Major Market Areas and Its Competitors
Table 105. Merck Details, Company Total Revenue (in $ million), Head Office, Preimplantation Genetic Diagnostics (PGD) Major Market Areas and Its Competitors
Table 106. Vitrolife AB Details, Company Total Revenue (in $ million), Head Office, Preimplantation Genetic Diagnostics (PGD) Major Market Areas and Its Competitors
Table 107. Scigene Details, Company Total Revenue (in $ million), Head Office, Preimplantation Genetic Diagnostics (PGD) Major Market Areas and Its Competitors
Table 108. Hamilton Thorne Details, Company Total Revenue (in $ million), Head Office, Preimplantation Genetic Diagnostics (PGD) Major Market Areas and Its Competitors
Table 109. Genea Limited Details, Company Total Revenue (in $ million), Head Office, Preimplantation Genetic Diagnostics (PGD) Major Market Areas and Its Competitors
Table 110. IVFtech Details, Company Total Revenue (in $ million), Head Office, Preimplantation Genetic Diagnostics (PGD) Major Market Areas and Its Competitors
Table 111. FUJIFILM Irvine Scientific Details, Company Total Revenue (in $ million), Head Office, Preimplantation Genetic Diagnostics (PGD) Major Market Areas and Its Competitors
Table 112. Beijing Genomics Institute (BGI) Details, Company Total Revenue (in $ million), Head Office, Preimplantation Genetic Diagnostics (PGD) Major Market Areas and Its Competitors
Table 113. INVO Bioscience Details, Company Total Revenue (in $ million), Head Office, Preimplantation Genetic Diagnostics (PGD) Major Market Areas and Its Competitors
Table 114. Cook Medical Details, Company Total Revenue (in $ million), Head Office, Preimplantation Genetic Diagnostics (PGD) Major Market Areas and Its Competitors
Table 115. CellCura Details, Company Total Revenue (in $ million), Head Office, Preimplantation Genetic Diagnostics (PGD) Major Market Areas and Its Competitors
Table 116. Gonagen Medikal Details, Company Total Revenue (in $ million), Head Office, Preimplantation Genetic Diagnostics (PGD) Major Market Areas and Its Competitors
List of Figures
Figure 1. Preimplantation Genetic Diagnostics (PGD) Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global Preimplantation Genetic Diagnostics (PGD) Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Type (2015-2020)
Figure 5. Global Preimplantation Genetic Screening Market Size Growth Rate
Figure 6. Global Preimplantation Genetic Diagnosis Market Size Growth Rate
Figure 7. Preimplantation Genetic Diagnostics (PGD) in Fertility Clinics
Figure 8. Global Preimplantation Genetic Diagnostics (PGD) Market: Fertility Clinics (2015-2020) ($ Millions)
Figure 9. Preimplantation Genetic Diagnostics (PGD) in Academic Medical Centers
Figure 10. Global Preimplantation Genetic Diagnostics (PGD) Market: Academic Medical Centers (2015-2020) ($ Millions)
Figure 11. Preimplantation Genetic Diagnostics (PGD) in Others
Figure 12. Global Preimplantation Genetic Diagnostics (PGD) Market: Others (2015-2020) ($ Millions)
Figure 13. Global Others YoY Growth ($ Millions)
Figure 14. Global Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Application in 2019
Figure 15. Global Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Regions 2015-2020
Figure 16. Americas Preimplantation Genetic Diagnostics (PGD) Market Size 2015-2020 ($ Millions)
Figure 17. APAC Preimplantation Genetic Diagnostics (PGD) Market Size 2015-2020 ($ Millions)
Figure 18. Europe Preimplantation Genetic Diagnostics (PGD) Market Size 2015-2020 ($ Millions)
Figure 19. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size 2015-2020 ($ Millions)
Figure 20. Americas Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Countries in 2019
Figure 21. Americas Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Type in 2019
Figure 22. Americas Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Application in 2019
Figure 23. United States Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2015-2020 ($ Millions)
Figure 24. Canada Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2015-2020 ($ Millions)
Figure 25. Mexico Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2015-2020 ($ Millions)
Figure 26. APAC Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Regions in 2019
Figure 27. APAC Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Type in 2019
Figure 28. APAC Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Application in 2019
Figure 29. China Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2015-2020 ($ Millions)
Figure 30. Japan Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2015-2020 ($ Millions)
Figure 31. Korea Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2015-2020 ($ Millions)
Figure 32. Southeast Asia Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2015-2020 ($ Millions)
Figure 33. India Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2015-2020 ($ Millions)
Figure 34. Australia Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2015-2020 ($ Millions)
Figure 35. Europe Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Countries in 2019
Figure 36. Europe Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Type in 2019
Figure 37. Europe Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Application in 2019
Figure 38. Germany Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2015-2020 ($ Millions)
Figure 39. France Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2015-2020 ($ Millions)
Figure 40. UK Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2015-2020 ($ Millions)
Figure 41. Italy Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2015-2020 ($ Millions)
Figure 42. Russia Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2015-2020 ($ Millions)
Figure 43. Spain Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2015-2020 ($ Millions)
Figure 44. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Countries in 2019
Figure 45. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Type in 2019
Figure 46. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Application in 2019
Figure 47. Egypt Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2015-2020 ($ Millions)
Figure 48. South Africa Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2015-2020 ($ Millions)
Figure 49. Israel Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2015-2020 ($ Millions)
Figure 50. Turkey Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2015-2020 ($ Millions)
Figure 51. GCC Countries Preimplantation Genetic Diagnostics (PGD) Market Size Growth 2015-2020 ($ Millions)
Figure 52. Global Preimplantation Genetic Diagnostics (PGD) arket Size Forecast (2021-2025) ($ Millions)
Figure 53. Americas Preimplantation Genetic Diagnostics (PGD) Market Size 2021-2025 ($ Millions)
Figure 54. APAC Preimplantation Genetic Diagnostics (PGD) Market Size 2021-2025 ($ Millions)
Figure 55. Europe Preimplantation Genetic Diagnostics (PGD) Market Size 2021-2025 ($ Millions)
Figure 56. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size 2021-2025 ($ Millions)
Figure 57. United States Preimplantation Genetic Diagnostics (PGD) Market Size 2021-2025 ($ Millions)
Figure 58. Canada Preimplantation Genetic Diagnostics (PGD) Market Size 2021-2025 ($ Millions)
Figure 59. Mexico Preimplantation Genetic Diagnostics (PGD) Market Size 2021-2025 ($ Millions)
Figure 60. Brazil Preimplantation Genetic Diagnostics (PGD) Market Size 2021-2025 ($ Millions)
Figure 61. China Preimplantation Genetic Diagnostics (PGD) Market Size 2021-2025 ($ Millions)
Figure 62. Japan Preimplantation Genetic Diagnostics (PGD) Market Size 2021-2025 ($ Millions)
Figure 63. Korea Preimplantation Genetic Diagnostics (PGD) Market Size 2021-2025 ($ Millions)
Figure 64. Southeast Asia Preimplantation Genetic Diagnostics (PGD) Market Size 2021-2025 ($ Millions)
Figure 65. India Preimplantation Genetic Diagnostics (PGD) Market Size 2021-2025 ($ Millions)
Figure 66. Australia Preimplantation Genetic Diagnostics (PGD) Market Size 2021-2025 ($ Millions)
Figure 67. Germany Preimplantation Genetic Diagnostics (PGD) Market Size 2021-2025 ($ Millions)
Figure 68. France Preimplantation Genetic Diagnostics (PGD) Market Size 2021-2025 ($ Millions)
Figure 69. UK Preimplantation Genetic Diagnostics (PGD) Market Size 2021-2025 ($ Millions)
Figure 70. Italy Preimplantation Genetic Diagnostics (PGD) Market Size 2021-2025 ($ Millions)
Figure 71. Russia Preimplantation Genetic Diagnostics (PGD) Market Size 2021-2025 ($ Millions)
Figure 72. Spain Preimplantation Genetic Diagnostics (PGD) Market Size 2021-2025 ($ Millions)
Figure 73. Egypt Preimplantation Genetic Diagnostics (PGD) Market Size 2021-2025 ($ Millions)
Figure 74. South Africa Preimplantation Genetic Diagnostics (PGD) Market Size 2021-2025 ($ Millions)
Figure 75. Israel Preimplantation Genetic Diagnostics (PGD) Market Size 2021-2025 ($ Millions)
Figure 76. Turkey Preimplantation Genetic Diagnostics (PGD) Market Size 2021-2025 ($ Millions)
Figure 77. GCC Countries Preimplantation Genetic Diagnostics (PGD) Market Size 2021-2025 ($ Millions)

Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets